Release Date: 27/05/10 10:03 Summary: Polish Concession for Myszkow Extended Price Sensitive: Yes Download Document 355.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%